Cargando…

The functional impact of variants of uncertain significance in BRCA2

PURPOSE: Genetic testing has uncovered large numbers of variants in the BRCA2 gene for which the clinical significance is unclear. Cancer risk prediction of these variants of uncertain significance (VUS) can be improved by reliable assessment of the extent of impairment of the tumor suppressor funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mesman, Romy L. S., Calléja, Fabienne M. G. R., Hendriks, Giel, Morolli, Bruno, Misovic, Branislav, Devilee, Peter, van Asperen, Christi J., Vrieling, Harry, Vreeswijk, Maaike P. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752316/ https://www.ncbi.nlm.nih.gov/pubmed/29988080 http://dx.doi.org/10.1038/s41436-018-0052-2

Ejemplares similares

Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2
por: Mesman, Romy L. S., et al.
Publicado: (2020)

Correction: Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2
por: Mesman, Romy L. S., et al.
Publicado: (2020)

A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history
por: Gómez García, Encarna B, et al.
Publicado: (2009)

Missense Variants of Uncertain Significance (VUS) Altering the Phosphorylation Patterns of BRCA1 and BRCA2
por: Tram, Eric, et al.
Publicado: (2013)

An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance
por: Iversen, Edwin S., et al.
Publicado: (2022)

Functional Characterization of PALB2 Variants of Uncertain Significance: Toward Cancer Risk and Therapy Response Prediction
por: Boonen, Rick A. C. M., et al.
Publicado: (2020)

Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?
por: Cheon, Jae Yeon, et al.
Publicado: (2014)

Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain Significance
por: Sorscher, Steven, et al.
Publicado: (2017)

A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example
por: Mohammadi, Leila, et al.
Publicado: (2009)

Mechanism-based genotoxicity screening of metal oxide nanoparticles using the ToxTracker panel of reporter cell lines
por: Karlsson, Hanna L, et al.
Publicado: (2014)

GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes
por: Caleca, Laura, et al.
Publicado: (2019)

Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
por: Fanale, Daniele, et al.
Publicado: (2021)

BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
por: Jonsdottir, Asta Björk, et al.
Publicado: (2009)

Erratum: Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
Publicado: (2022)

Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance
por: Richardson, Marcy E., et al.
Publicado: (2021)

Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance
por: Lyra, Paulo C. M., et al.
Publicado: (2020)

Variants of Uncertain Significance and “Missing Pathogenicity”
por: Fatkin, Diane, et al.
Publicado: (2020)

Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance
por: Ozgencil, Meryem, et al.
Publicado: (2021)

Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of BRCA1/2 Variants of Uncertain Significance
por: Gelli, Elisa, et al.
Publicado: (2019)

Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
por: Li, Hongyan, et al.
Publicado: (2019)

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2019)

Exome Sequencing of Germline DNA from Non-BRCA1/2 Familial Breast Cancer Cases Selected on the Basis of aCGH Tumor Profiling
por: Hilbers, Florentine S., et al.
Publicado: (2013)

Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules
por: Jimenez-Sainz, Judit, et al.
Publicado: (2021)

Estrogen receptor transcription and transactivation: Genetic modifiers of cancer risks conferred by BRCA1 and BRCA2
por: Devilee, P
Publicado: (2001)

Clustering of known low and moderate risk alleles rather than a novel recessive high‐risk gene in non‐BRCA1/2 sib trios affected with breast cancer
por: Hilbers, Florentine S., et al.
Publicado: (2020)

Functional characterization of 84 PALB2 variants of uncertain significance
por: Wiltshire, Timothy, et al.
Publicado: (2019)

To offer or request? Disclosing variants of uncertain significance in prenatal testing
por: Watts, Gabriel, et al.
Publicado: (2021)

Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay
por: Hu, Chunling, et al.
Publicado: (2022)

Genome-wide scanning for linkage in 56 Dutch breast cancer families selected for a minimal probability of being due to BRCA1 or BRCA2
por: Oldenburg, RA, et al.
Publicado: (2005)

The Clinical Significance of Unknown Sequence Variants in BRCA Genes
por: Calò, Valentina, et al.
Publicado: (2010)

Clinical significance of variants of unknown significances in BRCA genes
por: Choi, Min Chul
Publicado: (2019)

Quantitative phosphoproteomics to unravel the cellular response to chemical stressors with different modes of action
por: Sampadi, Bharath, et al.
Publicado: (2020)

'A variant of uncertain significance' and the proliferation of human disease gene databases
por: Nelson, David R
Publicado: (2005)

The known unknown: the challenges of genetic variants of uncertain significance in clinical practice
por: Hoffman-Andrews, Lily
Publicado: (2018)

Classification of MSH6 Variants of Uncertain Significance Using Functional Assays
por: Frederiksen, Jane H., et al.
Publicado: (2021)

Cancer patients’ understandings of genetic variants of uncertain significance in clinical care
por: Amano, Yael, et al.
Publicado: (2022)

Transcriptome analysis provides critical answers to the “variants of uncertain significance” conundrum
por: Postel, Mackenzie D., et al.
Publicado: (2022)

Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing
por: Chen, Elaine, et al.
Publicado: (2023)

Basic science methods for the characterization of variants of uncertain significance in hypertrophic cardiomyopathy
por: Doh, Chang Yoon, et al.
Publicado: (2023)

On the significance of edges for connectivity in uncertain random graphs
por: Li, Hao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2pqh25eepht1lnfp76btngk0el